文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

实验性多发伤与失血性休克后的脑部改变

Cerebral Alterations Following Experimental Multiple Trauma and Hemorrhagic Shock.
PubMed 文献 · Shock · 2018-01-01
一句话结论猪多发伤/失血性休克模型在120分钟内复苏未发现大体脑损伤,但出现小胶质细胞活化与M1极化;延迟亚低温未显示神经保护作用。

该研究采用无创伤性脑损伤的猪多发伤合并失血性休克模型,在失血量45%或50%、90或120分钟后进行复苏,并设置复苏后33°C轻度治疗性亚低温组及常温/亚低温假手术对照。监测颅内压、脑灌注压(CPP)和脑组织氧分压(PtiO2)至48.5小时,检测血清S-100B和NSE,并行脑组织炎症与Iba1、S100、iNOS免疫组化。多发伤/失血性休克后CPP和PtiO2立即显著低于假手术组,复苏后逐渐恢复;T90和T90/T120组血清S-100B和NSE分别出现一过性升高;所有组均见脑炎症,T90和T120组Iba1染色显示显著小胶质细胞增生,iNOS染色提示M1极化。轻度亚低温减少TH90组脑炎症但增加iNOS活化;在120分钟内开始复苏未发现大体脑损伤证据,但创伤相关小胶质细胞活化和M1极化可能为暂时性缺氧/缺血的后果,需进一步研究机制;延迟启动的轻度亚低温未显示神经保护特性。

要点

  • 猪多发伤/失血性休克(无创伤性脑损伤)后CPP和PtiO2立即显著低于假手术组,复苏后两者逐渐恢复。
  • T90和T90/T120组血清S-100B和NSE分别出现一过性升高,提示短暂血脑屏障或神经元损伤信号。
  • 所有组均见脑炎症;T90和T120组Iba1染色显示显著小胶质细胞增生,iNOS染色提示M1极化。
  • 轻度亚低温(33°C)减少TH90组脑炎症,但增加iNOS活化;延迟启动的轻度亚低温未显示神经保护特性。
  • 在多发伤/失血性休克后120分钟内开始复苏,该猪长期模型未发现大体脑损伤证据。

适用人群与场景

  • 雄性猪,标准化多发伤合并失血性休克(失血量45%或50%),无创伤性脑损伤。
  • 复苏在伤后90或120分钟开始;亚低温组在复苏后诱导33°C轻度低温。
  • 常温或亚低温假手术动物作为对照。

处置流程与药物剂量

  • 多发伤合并失血性休克后90或120分钟开始复苏;TH90/TH120组在复苏后诱导33°C轻度治疗性亚低温。
  • 监测颅内压、脑灌注压(CPP)和脑组织氧分压(PtiO2)至48.5小时。
  • 用ELISA检测血清蛋白S-100B和神经元特异性烯醇化酶(NSE)。
  • HE染色脑切片量化脑炎症;免疫组化评估Iba1、S100和诱导型一氧化氮合酶(iNOS)表达。

研究设计与关键结果

  • 研究类型:猪长期实验模型;人群:雄性猪多发伤合并失血性休克(无创伤性脑损伤);干预:伤后90或120分钟复苏,部分组复苏后33°C轻度亚低温;对照:常温或亚低温假手术动物。
  • 多发伤/失血性休克后,T90/T120组CPP和PtiO2立即显著低于假手术组,复苏后两者逐渐恢复。
  • 血清S-100B在T90组、NSE在T90/T120组因多发伤/失血性休克出现一过性升高。
  • 所有组均见脑炎症;T90和T120组Iba1染色显示显著小胶质细胞增生,iNOS染色提示M1极化。
  • 轻度亚低温减少TH90组脑炎症,但导致iNOS活化增加。
  • 在多发伤/失血性休克后120分钟内开始复苏,未发现大体脑损伤证据;但创伤相关小胶质细胞活化和M1极化可能为暂时性缺氧/缺血的后果,需进一步研究以明确潜在机制;延迟启动的轻度亚低温未显示神经保护特性。

证据类型、等级与局限

  • 证据类型:动物实验(猪长期模型)。
  • 局限:原文报告需进一步研究以明确潜在机制;原文未报告其他局限性。

对床旁实践的改变

  • 该猪模型提示,无创伤性脑损伤的多发伤/失血性休克在120分钟内开始复苏未发现大体脑损伤,但存在小胶质细胞活化和M1极化。
  • 作者认为创伤相关小胶质细胞活化和M1极化可能为暂时性缺氧/缺血的后果,需进一步研究以明确潜在机制。
  • 该模型中延迟启动的轻度亚低温未显示神经保护特性,且轻度亚低温减少TH90组脑炎症但增加iNOS活化。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Multiple trauma (MT) associated with hemorrhagic shock (HS) might lead to cerebral hypoperfusion and brain damage. We investigated cerebral alterations using a new porcine MT/HS model without traumatic brain injury (TBI) and assessed the neuroprotective properties of mild therapeutic hypothermia. Male pigs underwent standardized MT with HS (45% or 50% loss of blood volume) and resuscitation after 90/120 min (T90/T120). In additional groups (TH90/TH120) mild hypothermia (33°C) was induced following resuscitation. Normothermic or hypothermic sham animals served as controls. Intracranial pressure, cerebral perfusion pressure (CPP), and cerebral oxygenation (PtiO2) were recorded up to 48.5 h. Serum protein S-100B and neuron-specific enolase (NSE) were measured by ELISA. Cerebral inflammation was quantified on hematoxylin and eosin -stained brain slices; Iba1, S100, and inducible nitric oxide synthase (iNOS) expression was assessed using immunohistochemistry. Directly after MT/HS, CPP and PtiO2 were significantly lower in T90/T120 groups compared with sham. After resuscitation both parameters showed a gradual recovery. Serum protein S-100B and NSE increased temporarily as a result of MT/HS in T90 and T90/T120 groups, respectively. Cerebral inflammation was found in all groups. Iba1-staining showed significant microgliosis in T90 and T120 animals. iNOS-staining indicated a M1 polarization. Mild hypothermia reduced cerebral inflammation in the TH90 group, but resulted in increased iNOS activation. In this porcine long-term model, we did not find evidence of gross cerebral damage when resuscitation was initiated within 120 min after MT/HS without TBI. However, trauma-related microglia activation and M1 microglia polarization might be a consequence of temporary hypoxia/ischemia and further research is warranted to detail underlying mechanisms. Interestingly, mild hypothermia did not exhibit neuroprotective properties when initiated in a delayed fashion.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Vogt N, Herden C, Roeb E, et al. Cerebral Alterations Following Experimental Multiple Trauma and Hemorrhagic Shock. Shock. 2018. PMID: 28682946. doi:10.1097/SHK.0000000000000943

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。